Heal
-
DATABASE (312)
-
ARTICLES (3)
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Proxima Ventures was founded in 2016 in Shanghai. It manages both RMB and US dollar funds, worth around US$150m in total. The firm invests mainly in early-stage startups in the healthcare sector. It has invested in 18 companies and established six innovation centers to incubate medtech startups.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Spring Fund was founded in Beijing in May 2015 with RMB 300m initial funding. Its cornerstone investors include government guidance funds and Chunyu Mobile Health. Spring Fund mainly invests in the early stages of mobile healthtechs and startups with focus on intelligent hardware, smart assistance, online diagnosis, chronic disease management, cross-border healthcare, rural areas and the elderly population.
Spring Fund was founded in Beijing in May 2015 with RMB 300m initial funding. Its cornerstone investors include government guidance funds and Chunyu Mobile Health. Spring Fund mainly invests in the early stages of mobile healthtechs and startups with focus on intelligent hardware, smart assistance, online diagnosis, chronic disease management, cross-border healthcare, rural areas and the elderly population.
Sinopharm-CICC Capital was co-founded by Sinopharm and China International Capital Corporation (CICC) in October 2016. It focuses on investments in the healthcare industry.
Sinopharm-CICC Capital was co-founded by Sinopharm and China International Capital Corporation (CICC) in October 2016. It focuses on investments in the healthcare industry.
Founded in 2005, Fortune Link focuses on private equity investment. Its founder, Kan Zhidong was also the founder of Shenzhen Capital Group, one of the first few venture capitalists in China. As at March 2018, it had set up a number of funds and managed over 20 investment teams.With over RMB 30bn worth of assets under its management, Fortune Link mainly invests in sectors including TMT, environmental protection, advanced material, healthcare, high tech industries, culture and media.
Founded in 2005, Fortune Link focuses on private equity investment. Its founder, Kan Zhidong was also the founder of Shenzhen Capital Group, one of the first few venture capitalists in China. As at March 2018, it had set up a number of funds and managed over 20 investment teams.With over RMB 30bn worth of assets under its management, Fortune Link mainly invests in sectors including TMT, environmental protection, advanced material, healthcare, high tech industries, culture and media.
Founded in Beijing in 2015, Frees Fund is an asset management company with a portfolio valued at RMB 3.6bn. Frees primarily invests in early-stage startups in diverse sectors including fintech, education, healthcare, entertainment, hardware, intelligent manufacturing and SaaS. The VC is incorporated as Shanghai Ziyou Investment Management Co Ltd.
Founded in Beijing in 2015, Frees Fund is an asset management company with a portfolio valued at RMB 3.6bn. Frees primarily invests in early-stage startups in diverse sectors including fintech, education, healthcare, entertainment, hardware, intelligent manufacturing and SaaS. The VC is incorporated as Shanghai Ziyou Investment Management Co Ltd.
AddVenture is a Russian VC fund investing internationally. The firm has US$120m under management, participating in funding rounds with an investment range between US$1m and US$10m. The firm’s portfolio comprises 23 investments and five exits.AddVenture's investment criteria focus on local services, marketplaces, SaaS, food-tech and health-tech startups.
AddVenture is a Russian VC fund investing internationally. The firm has US$120m under management, participating in funding rounds with an investment range between US$1m and US$10m. The firm’s portfolio comprises 23 investments and five exits.AddVenture's investment criteria focus on local services, marketplaces, SaaS, food-tech and health-tech startups.
Albert Armengol is the CEO and co-founder of Doctoralia, an online platform for searching and booking medical assistance. He is also the founder of eConozco (sold to XING AG).Armengol has a healthcare and business background and developed his professional career in the healthcare and insurance sector. He later moved to technology and internet startups as an entrepreneur and angel investor.
Albert Armengol is the CEO and co-founder of Doctoralia, an online platform for searching and booking medical assistance. He is also the founder of eConozco (sold to XING AG).Armengol has a healthcare and business background and developed his professional career in the healthcare and insurance sector. He later moved to technology and internet startups as an entrepreneur and angel investor.
Greycroft is a New York-based VC, established in 2006, that currently has 113 companies in its portfolio. It has interests in multiple sectors but a preference for A.I. and Big Data technologies underpinning them. It has managed 35 exits to date including Farfetch and Huffington Post. Its recent investments include in the US$60m Series C financing round of multilingual AI-driven translation platform Unbabel and in the US$22m Series A round of Kheiron, a breast cancer-detecting health tech.
Greycroft is a New York-based VC, established in 2006, that currently has 113 companies in its portfolio. It has interests in multiple sectors but a preference for A.I. and Big Data technologies underpinning them. It has managed 35 exits to date including Farfetch and Huffington Post. Its recent investments include in the US$60m Series C financing round of multilingual AI-driven translation platform Unbabel and in the US$22m Series A round of Kheiron, a breast cancer-detecting health tech.
IGF is a crowdfunding platform for impact investing in Asia. It aims to partner with innovative, high-impact enterprises in need of capital to scale their businesses and, as a result, be of value to society and the environment. The fund seeks to mobilize its US$50m in investment capital to deliver affordable healthcare, cut CO2 emissions, help more than 2m people gain access to clean energy and empower women. IGF's investments range in size from US$250,000 to US$5m, and primarily take the form of equity or quasi-equity. All its investments include pre-agreed social or environmental impact targets.
IGF is a crowdfunding platform for impact investing in Asia. It aims to partner with innovative, high-impact enterprises in need of capital to scale their businesses and, as a result, be of value to society and the environment. The fund seeks to mobilize its US$50m in investment capital to deliver affordable healthcare, cut CO2 emissions, help more than 2m people gain access to clean energy and empower women. IGF's investments range in size from US$250,000 to US$5m, and primarily take the form of equity or quasi-equity. All its investments include pre-agreed social or environmental impact targets.
LGT Venture Philanthropy is an independent charitable foundation that supports organizations and companies which implement solutions that contribute to the achievement of sustainable development goals. It strives to improve the quality of life of disadvantaged people, contribute to healthy ecosystems and build resilient, inclusive and prosperous communities. LGT supports the growth of innovative social organizations by providing them with a tailored combination of growth capital, access to business skills, management know-how and strategic advice.
LGT Venture Philanthropy is an independent charitable foundation that supports organizations and companies which implement solutions that contribute to the achievement of sustainable development goals. It strives to improve the quality of life of disadvantaged people, contribute to healthy ecosystems and build resilient, inclusive and prosperous communities. LGT supports the growth of innovative social organizations by providing them with a tailored combination of growth capital, access to business skills, management know-how and strategic advice.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Founded in 2014, Prosperico Ventures targets the healthcare sector. The VC has invested in nearly 30 startups working on medical devices, pharmaceutical R&D, provision of medical services and precision medicine.
Founded by former IDG Capital partner Zhang Suyang in May 2016, the Shanghai-based VC firm invests mainly in early-stage startups working on tech innovations and healthcare. Total assets under management exceed RMB 2.2bn.
Founded by former IDG Capital partner Zhang Suyang in May 2016, the Shanghai-based VC firm invests mainly in early-stage startups working on tech innovations and healthcare. Total assets under management exceed RMB 2.2bn.
Everis is a Madrid-based consulting firm that was acquired in 2014 by Japan's NTT Data, the sixth-largest IT services company in the world. With a turnover of €1.17bn, the company offers consultancy services in banking, healthcare, industry, insurance, media, public sector and telecommunications across Europe, in Latin America and the US. The company has established an innovation center, NextGen, focusing on technologies that drive business disruption, such as, Cloud models, Blockchain, Big Data, AI and Robotics.
Everis is a Madrid-based consulting firm that was acquired in 2014 by Japan's NTT Data, the sixth-largest IT services company in the world. With a turnover of €1.17bn, the company offers consultancy services in banking, healthcare, industry, insurance, media, public sector and telecommunications across Europe, in Latin America and the US. The company has established an innovation center, NextGen, focusing on technologies that drive business disruption, such as, Cloud models, Blockchain, Big Data, AI and Robotics.
Neurafarm: Putting an AI plant doctor in farmers' hands
This startup is riding on Indonesia’s urban farming trend with its planting kit and an AI-powered app that identifies plant diseases from photos of unhealthy leaves
HypeLabs wins bumper US$3m seed funding to democratize connectivity
HypeLab's P2P mesh networking technology enables everyone to communicate within their own networks without needing internet, in cities, remote villages and even in disaster zones
Knokcare: Telemedicine app connects you to doctors in 30 minutes
Seeking funding of over €1m, Portugal’s digital healthcare pioneer is expanding its SaaS to tap new markets in Europe, Africa and Latin America
Sorry, we couldn’t find any matches for “Heal”.